<DOC>
	<DOCNO>NCT00546728</DOCNO>
	<brief_summary>The purpose study compare effect exenatide versus metformin vascular health chronic ( 3-month ) therapy 2-hour period follow meal patient pre-diabetes . It predict exenatide improve vascular health great degree compare metformin .</brief_summary>
	<brief_title>The Vascular Effects Exenatide Versus Metformin Patients With Pre-Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Greater equal 18 year old Impaired glucose tolerance : 2hr oral glucose tolerance test ( OGTT ) plasma glucose &gt; 140 mg/dL OR impair fast glucose : fasting glucose &gt; = 100 mg/dL OR elevate glycosylated hemoglobin : Hemoglobin A1c &gt; = 5.7 % Abdominal obesity : waist circumference &gt; 102 cm ( men ) &gt; 88 cm ( woman ) Stable cardiovascular medication regimen ( medication know affect endothelial function ) least 1 month prior enrollment throughout study Type 2 diabetes Current use glycemic control medication within one month randomization Fasting glucose &gt; 126 mg/dL Current use weight loss medication Previous weight loss surgery History severe gastrointestinal disease Standard clinical contraindication exenatide metformin therapy Unstable angina Heart failure Stroke coronary artery bypass graft within 3 month screen Women currently pregnant plan become pregnant Breastfeeding woman Clinically significant liver disease Creatinine &gt; 1.5 mg/dL Hepatic function great 3 time upper limit normal Patients mentally incompetent sign Patient Informed Consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>